Home / People / DoubleBlindWe Need Trip-Free Psychedelics in MedicineDoubleBlindMon, Dec 9Psychedelics are at a crossroads. Legalization efforts are stalling, concerns over safety are mounting, and the industry is learning hard lessons. Could “trip-free” psychedelics be the solution? Our latest: https://t.co/xcPUI4vBmA171005Scientists are on the brink of developing treatments for Alzheimer’s Disease, chronic pain, traumatic brain injuries, and more with trip-free psychedelic molecules.Read More Discover DoubleBlindNewsCannabisPsychedelicsAddictionDispensaryHealthOpioidsScience